Health
Start-up receives NIH grant to accelerate development of contrast agent to detect liver fibrosis – News-Medical.Net
Inlighta Biosciences, LLC, a start-up company led by Jenny Yang, Regents’ Professor of Chemistry at Georgia State University, has been awarded a National Instit…
Reviewed by Emily Henderson, B.Sc.Oct 15 2020
Inlighta Biosciences, LLC, a start-up company led by Jenny Yang, Regents’ Professor of Chemistry at Georgia State University, has been awarded a National Institute of Health grant to accelerate development of a magnetic resonance imaging contrast agent to detect liver fibrosis, formation of scar tissue in the liver caused by alcoholic and non-alcoholic fatty liver disease.
We have been working on this breakthrough in the lab for several years. This…
-
Noosa News24 hours agoHusband charged after beloved Brisbane nurse Carra Luke allegedly stabbed to death in Taigum home
-
Noosa News23 hours agoRallies under way as nationwide support for Palestine surges
-
General23 hours agoTens of thousands protest in nationwide action against war in Gaza
-
General22 hours agoAuthorities say charged man used false name to escape from Perth court